Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.0K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

84.6K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
84.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.0K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Behavioral Features in Phelan-McDermid Syndrome: Characteristics and Genetic and Metabolic Contributions in a Cohort of 56 Individuals.

Genes·2026
Same author

The methyl-CpG-binding protein 2 inhibits cGAS-associated signaling.

Nature communications·2025
Same author

Relationship Between Intellectual Disability and Behavioral Comorbidity in Children With Fragile X Syndrome.

Journal of autism and developmental disorders·2025
Same author

Study of trofinetide in Rett syndrome: Lessons from an approved drug for a severe neurodevelopmental disorder.

Developmental medicine and child neurology·2025
Same author

Publisher Correction: Rett syndrome.

Nature reviews. Disease primers·2025
Same author

The Aberrant Behavior Checklist for Fragile X Syndrome: A Qualitative Clinician Evaluation of Content Validity.

Journal of child and adolescent psychopharmacology·2025

Related Experiment Video

Updated: Dec 12, 2025

Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions
10:32

Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions

Published on: January 18, 2016

14.6K

Functional Network Mapping Reveals State-Dependent Response to IGF1 Treatment in Rett Syndrome.

Conor Keogh1, Giorgio Pini2, Ilaria Gemo2

  • 1Department of Surgery, University Hospital Limerick, V94 F858 Limerick, Ireland.

Brain Sciences
|August 7, 2020
PubMed
Summary
This summary is machine-generated.

Insulin-Like Growth Factor 1 (IGF1) shows promise in treating Rett Syndrome (RTT) by improving cortical network function. Network analysis accurately predicted treatment response, suggesting potential biomarkers for RTT clinical trials.

Keywords:
EEGIGF1Rett Syndromeelectrophysiologymachine learningnetwork

More Related Videos

Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
07:43

Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders

Published on: May 12, 2015

11.6K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.5K

Related Experiment Videos

Last Updated: Dec 12, 2025

Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions
10:32

Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions

Published on: January 18, 2016

14.6K
Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
07:43

Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders

Published on: May 12, 2015

11.6K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.5K

Area of Science:

  • Neuroscience
  • Genetics
  • Biomedical Engineering

Background:

  • Rett Syndrome (RTT) is a severe neurodevelopmental disorder caused by mutations in the MeCP2 gene, impacting cortical network development.
  • Insulin-Like Growth Factor 1 (IGF1) has shown potential in preclinical models and early human trials for ameliorating RTT phenotypes.
  • The precise impact of IGF1 on cortical electrophysiology and its correlation with clinical outcomes in RTT patients remain largely unexplored.

Purpose of the Study:

  • To investigate the effect of IGF1 treatment on cortical electrophysiology in RTT patients.
  • To determine if electrophysiological changes correlate with clinical response to IGF1 therapy.
  • To explore the utility of baseline network characteristics in predicting treatment response.

Main Methods:

  • Resting-state electroencephalogram (EEG) recordings and clinical assessments were performed on 18 RTT patients (9 treated with IGF1).
  • Network measures were derived from interelectrode coherence using statistical modeling.
  • Machine learning models were applied to baseline EEG data to predict treatment response.

Main Results:

  • IGF1 treatment significantly altered network measures in RTT patients.
  • Changes in network measures were strongly associated with clinical response to IGF1.
  • Baseline network characteristics predicted treatment response with 100% accuracy in this cohort.

Conclusions:

  • Cortical network dysfunction is a key pathological feature of RTT.
  • IGF1 treatment impacts cortical electrophysiology in RTT patients, with changes linked to clinical improvement.
  • Network measures show promise as biomarkers for characterizing RTT subtypes and predicting treatment efficacy in clinical trials.